| Revision as of 00:17, 1 July 2011 editCheMoBot (talk | contribs)Bots141,565 edits Updating {{chembox}} (changes to verified fields - updated 'KEGG_Ref') per Chem/Drugbox validation (report errors or bugs)← Previous edit |
Latest revision as of 19:12, 2 June 2021 edit undoSdkbBot (talk | contribs)Bots356,382 editsm →Australia: removed erroneous spaceTag: AWB |
| (21 intermediate revisions by 14 users not shown) |
| Line 1: |
Line 1: |
|
{{chembox |
|
{{chembox |
|
| Verifiedfields = changed |
|
| Watchedfields = changed |
|
⚫ |
| verifiedrevid = 437142907 |
| ⚫ |
| UNII_Ref = {{fdacite|changed|FDA}} |
|
|
⚫ |
| ImageFile = Dimiracetam.svg |
| ⚫ |
| UNII = 4AW7F70MZO |
|
|
|
| ImageName = Chemical structure of dimiracetam |
| ⚫ |
| verifiedrevid = 414429126 |
|
|
⚫ |
| ImageSize=150px |
| ⚫ |
| ImageFile = Dimiracetam.png |
|
|
⚫ |
| IUPACName = (''RS'')-3,6,7,7a-Tetrahydro-1''H''-pyrroloimidazole-2,5-dione |
|
| imagename = 1 : 1 mixture (racemate) |
|
| ⚫ |
| width = 150px |
|
| ⚫ |
| IUPACName = (''RS'')-3,6,7,7a-tetrahydro-1H-pyrroloimidazole-2,5-dione |
|
|
| OtherNames = |
|
| OtherNames = |
|
| Section1 = {{Chembox Identifiers |
|
|Section1={{Chembox Identifiers |
|
⚫ |
| UNII_Ref = {{fdacite|correct|FDA}} |
|
⚫ |
| UNII = 4AW7F70MZO |
|
| PubChem = 65955 |
|
| PubChem = 65955 |
|
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
| Line 22: |
Line 22: |
|
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChIKey = XTXXOHPHLNROBN-UHFFFAOYSA-N |
|
| StdInChIKey = XTXXOHPHLNROBN-UHFFFAOYSA-N |
|
|
| CASNo_Ref = {{cascite|correct|??}} |
|
| CASNo =126100-97-8 |
|
| CASNo =126100-97-8 |
|
| ATCCode_prefix = |
|
|
| ATCCode_suffix = |
|
|
| SMILES= C1CC(=O)N2C1NC(=O)C2 }} |
|
| SMILES= C1CC(=O)N2C1NC(=O)C2 }} |
|
| Section2 = {{Chembox Properties |
|
|Section2={{Chembox Properties |
|
| Formula = | C=6 | H=8 | N=2 | O=2 |
|
| Formula = |
|
|
| C=6 | H=8 | N=2 | O=2 |
|
| MolarMass = 140.140 g/mol |
|
|
| Appearance = |
|
| Appearance = |
|
| Density = |
|
| Density = |
| Line 34: |
Line 33: |
|
| BoilingPt = |
|
| BoilingPt = |
|
| Solubility = }} |
|
| Solubility = }} |
|
| Section5 = {{Chembox Pharmacology |
|
|Section5={{Chembox Pharmacology |
|
| AdminRoutes = |
|
| AdminRoutes = |
|
| Bioavail = |
|
| Bioavail = |
| Line 44: |
Line 43: |
|
| Legal_US = |
|
| Legal_US = |
|
| Legal_UK = |
|
| Legal_UK = |
|
| Legal_AU = |
|
| Legal_AU = S4 |
|
| Legal_CA = |
|
| Legal_CA = |
|
| PregCat = |
|
| Pregnancy_category = |
|
| PregCat_AU = |
|
| Pregnancy_AU = |
|
|
|
|
| PregCat_US = }} |
|
|
|
}} |
|
}} |
|
}} |
|
|
|
|
|
'''Dimiracetam''' is a ] drug of the ] family,<ref>{{cite journal | last1 = Pinza | first1 = M | last2 = Farina | first2 = C | last3 = Cerri | first3 = A | last4 = Pfeiffer | first4 = U | last5 = Riccaboni | first5 = MT | last6 = Banfi | first6 = S | last7 = Biagetti | first7 = R | last8 = Pozzi | first8 = O | last9 = Magnani | first9 = M | title = Synthesis and pharmacological activity of a series of dihydro-1H-pyrrolo1,2-aimidazole-2,5(3H,6H)-diones, a novel class of potent cognition enhancers | journal = Journal of medicinal chemistry | volume = 36 | issue = 26 | pages = 4214–20 | year = 1993 | pmid = 8277504 }}</ref> derivatives of which may have application in the treatment of ].<ref>{{cite journal | last1 = Farina | first1 = C | last2 = Gagliardi | first2 = S | last3 = Ghelardini | first3 = C | last4 = Martinelli | first4 = M | last5 = Norcini | first5 = M | last6 = Parini | first6 = C | last7 = Petrillo | first7 = P | last8 = Ronzoni | first8 = S | title = Synthesis and biological evaluation of novel dimiracetam derivatives useful for the treatment of neuropathic pain | journal = Bioorganic & medicinal chemistry | volume = 16 | issue = 6 | pages = 3224–32 | year = 2008 | pmid = 18171618 | doi = 10.1016/j.bmc.2007.12.015 }}</ref> |
|
'''Dimiracetam''' is a ] drug of the ] family,<ref>{{cite journal | vauthors = Pinza M, Farina C, Cerri A, Pfeiffer U, Riccaboni MT, Banfi S, Biagetti R, Pozzi O, Magnani M, Dorigotti L | display-authors = 6 | title = Synthesis and pharmacological activity of a series of dihydro-1H-pyrroloimidazole-2,5(3H,6H)-diones, a novel class of potent cognition enhancers | journal = Journal of Medicinal Chemistry | volume = 36 | issue = 26 | pages = 4214–20 | date = December 1993 | pmid = 8277504 | doi = 10.1021/jm00078a011 }}</ref> derivatives of which may have application in the treatment of ].<ref>{{cite journal | vauthors = Farina C, Gagliardi S, Ghelardini C, Martinelli M, Norcini M, Parini C, Petrillo P, Ronzoni S | display-authors = 6 | title = Synthesis and biological evaluation of novel dimiracetam derivatives useful for the treatment of neuropathic pain | journal = Bioorganic & Medicinal Chemistry | volume = 16 | issue = 6 | pages = 3224–32 | date = March 2008 | pmid = 18171618 | doi = 10.1016/j.bmc.2007.12.015 }}</ref> |
|
|
|
|
|
==References== |
|
== Legality == |
|
|
=== Australia === |
|
<references/> |
|
|
|
Dimiracetam is a schedule 4 substance in Australia under the ].<ref name="Poisons Stanrard">. comlaw.gov.au</ref> A schedule 4 substance is classified as "Prescription Only Medicine, or Prescription Animal Remedy – Substances, the use or supply of which should be by or on the order of persons permitted by State or Territory legislation to prescribe and should be available from a pharmacist on prescription."<ref name="Poisons Stanrard" /> |
|
|
|
|
|
== References == |
|
|
{{reflist}} |
|
|
|
|
|
{{Racetams}} |
|
{{Racetams}} |
| Line 64: |
Line 68: |
|
|
|
|
|
{{nervous-system-drug-stub}} |
|
{{nervous-system-drug-stub}} |
|
|
|
|
] |
|